The effects of Yoda1, a pharmacological activator of PIEZO1, were investigated on intracellular [Ca2+] ([Ca2+]i) and phosphatidylserine (PS) exposure in red cells from patients with sickle cell anaemia (SCA). Here, PIEZO1 is linked to autosomal dominant cerebellar ataxia.